Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.
The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source [1]. The FDA approved three ...
The global equine artificial insemination (AI) market is on a robust trajectory, projected to expand from USD 686.7 million ...
Money Talks News on MSN
CRISPR cures cholesterol, FDA demands testing
Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability ...
From a CRISPR baby to a young AI disruptor, 2025 has seen some serious leaps in science and technology. It's also seen some ...
Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.
Matthew Herper covers medical innovation — both its promise and its perils. It has been a tough year for medicine. The U.S.
Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...
In one of the rockiest years yet for science, Philadelphia-area researchers still managed to celebrate many wins. Here are five of them.
Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...
Scientists have developed a novel approach of genome editing to repair muscle stem (satellite) cells, offering new hope for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback